Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.

Lamarca, Angela; Barriuso, Jorge; McNamara, Mairéad G; Valle, Juan W

Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.

Lamarca, Angela; Barriuso, Jorge; McNamara, Mairéad G; Valle, Juan W.

Afiliação

Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Electronic address: angela.lamarca@christie.nhs.uk.
Barriuso J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
McNamara MG; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Electronic address: juan.valle@christie.nhs.uk.

J Hepatol ; 73(1): 170-185, 2020 07.

Article em En | MEDLINE | ID: mdl-32171892

Assuntos

Antineoplásicos/farmacologia; Neoplasias do Sistema Biliar; Colangiocarcinoma; Neoplasias da Vesícula Biliar; Terapia de Alvo Molecular/métodos; Neoplasias do Sistema Biliar/tratamento farmacológico; Neoplasias do Sistema Biliar/metabolismo; Neoplasias do Sistema Biliar/patologia; Colangiocarcinoma/tratamento farmacológico; Colangiocarcinoma/metabolismo; Colangiocarcinoma/patologia; Desenvolvimento de Medicamentos; Neoplasias da Vesícula Biliar/tratamento farmacológico; Neoplasias da Vesícula Biliar/metabolismo; Neoplasias da Vesícula Biliar/patologia; Humanos

Palavras-chave

Biliary tract cancer; Cholangiocarcinoma; FGFR; Fusion; Gallbladder cancer; IDH; Mutation; Targeted therapies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Colangiocarcinoma / Terapia de Alvo Molecular / Neoplasias da Vesícula Biliar / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google